Celldex Therapeutics (CLDX) EV to EBITDA (2010 - 2026)
Powered by 
Analysis
Celldex Therapeutics (CLDX) EV to EBITDA (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Celldex Therapeutics | 3.10 Bn | 3.10 Bn | -2.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27.33 |
| Mar 31, 2026 | -19.66 |
| Dec 31, 2025 | -14.79 |
| Sep 30, 2025 | -15.43 |
| Jun 30, 2025 | -11.29 |
| Mar 31, 2025 | -8.47 |
| Dec 31, 2024 | -16.99 |
| Sep 30, 2024 | -28.76 |
| Jun 30, 2024 | -35.64 |
| Mar 31, 2024 | -47.83 |
| Dec 31, 2023 | -37.64 |
| Sep 30, 2023 | -25.83 |
| Jun 30, 2023 | -40.68 |
| Mar 31, 2023 | -43.78 |
| Dec 31, 2022 | -64.51 |
| Sep 30, 2022 | -36.12 |
| Jun 30, 2022 | -24.84 |
| Mar 31, 2022 | -52.11 |
| Dec 31, 2021 | -68.70 |
| Sep 30, 2021 | -100.67 |